FDA approves Silicon Valley company's blood test for colorectal cancer screening among average-risk adults in the USA blood test by Guardant Health received FDA approval for colorectal cancer screening, marking the first blood test approved as a primary screening option, promising convenience and early detection potential.
F.D.A. Approves Blood Test for Colon Cancer DetectionThe FDA approved a new blood test for colorectal cancer, simpler than other screening methods, aiming to increase early-stage cancer detection and reduce cancer-related deaths.
FDA approves Silicon Valley company's blood test for colorectal cancer screening among average-risk adults in the USA blood test by Guardant Health received FDA approval for colorectal cancer screening, marking the first blood test approved as a primary screening option, promising convenience and early detection potential.
F.D.A. Approves Blood Test for Colon Cancer DetectionThe FDA approved a new blood test for colorectal cancer, simpler than other screening methods, aiming to increase early-stage cancer detection and reduce cancer-related deaths.
New blood test developed by Silicon Valley-based group screens for colon cancerColon cancer deaths are increasing among people under 50.Guardant Health's blood test detects early stages of colon cancer.